ISSCR

Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement
The two-year collaboration aims to enhance drug safety testing in order to bring promising therapies to patients.

CTI Medtech Award Nomination for Automated, Quality Controlled Cell Culturing System
Companies automated culturing solution receives nomination for an award by Innovation Promotion Agency CTI of the Swiss Confederation.

Fate Therapeutics Granted Exclusive License to Stem Cell Modulators for Osteo-Regeneration
The intellectual property rights covers small molecule compositions and methods for inducing bone formation granted by The Regents of the University of California.

European Centre of Excellence for Mouse Biology Celebrates its 10th Anniversary
Scientists investigating basic research topics have generated mouse models of over 20 different human diseases over the past 10 years.

Study of volumetric oxygen transfer coefficient in a Taylor vortex flow bioreactor
Department of Chemical Engineering, Federal University of Sao Carlos, P.O. Box 676, Post Code 13565-905, Sao Carlos, SP, Brazil.

In biochemical processes involving cultivation of animal cells, the supply of oxygen in culture medium is an extremely important parameter in the project of bioreactors and its operation. In this work, the global volumetric transfer coefficient of oxygen (KLa) is evaluated in a Taylor vortex flow bioreactor (TVFB) and a correlation of mass transfer, of this equipment, is proposed.

Reliable and Predictive In Vitro Assays for Myelotoxicity and Cardiotoxicity of Kinase Inhibitors
(1) ReachBio LLC, (2) Axiogenesis AG

Kinase inhibitors (KIs) represent a new class of rationally designed drugs. The success of Imatinib has prompted the development of other KIs for the treatment of various cancers and inflammation. Although more successful than conventional therapies, myelotoxicity and cardiotoxicity are often major side effects of KIs. In order to predict if newly developed molecules demonstrated significant myelotoxicity or cardiotoxicity, we assessed a number of TKIs using in vitro models.

Senior Director ADME
The RSA Group
Hatfield, Herts, UK

Mass Spectometry Scientist
Roswell Park Cancer Institute
Buffalo, NY, USA

Principal HTS Scientist
St. Jude Childrens Research Hospital
Memphis, TN, USA


Target Discovery World Congress, South San Francisco, CA, USA
04 August 2009 - 05 August 2009

Target Discovery World Congress will be a meeting focusing on the research looking to find new potential drugs for development. The topics will include presentations on the latest in screening platforms and new methods such as those in High Content and Label-Free Screening and will also focus on the work being done looking for new drug targets in some of the major protein families including Ion Channels, GPCRs, Protein Kinases, Nuclear Receptors and the Ubiquitin Pathway.

Epigenetics World Congress, Berlin, Germany
17 September 2009 - 18 September 2009

Welcome to the inaugural Epigenetics World Congress. This year's event will take place in the exciting city of Berlin.
  

Stem Cells for Cardiovascular Disease 2009
Select Biosciences Ltd

This is the latest and most up-to-date Worldwide Stem Cells Market Report from Select Biosciences, based on our continual industry coverage. Select Biosciences industry coverage in this report focuses on the technical, market, and clinical trials aspects of stem cells being developed for addressing the opportunities in the cardio and vascular disease spaces.

Stem Cells in Regenerative Medicine 2008 Market Report
Published September 2008

This is the latest and most up-to-date Worldwide Stem Cells Market Report from Select Biosciences. This report focuses on the worldwide Regenerative Medicine/Cellular Therapy Marketplace which is a major segment of the overall stem cells space.